MedTrace Logo

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

NCT00590109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 383

Last updated 2021-12-28

No results posted yet for this study

Summary

The purpose of this project is to further characterize inherited predisposition to breast cancer mediated by specific BRCA alleles (BRACA1 185delAG and 5382insC; BRCA2 6174delT) among Jewish women.

Conditions

Interventions

OTHER

Blood test

subjects will provide one 8ml blood sample drawn into one ACD tube and 16ml of blood drawn into two EDTA (purple top) tubes.

OTHER

Questionnaire

A questionnaire encompassing medical, environmental exposure, and reproductive history.

Sponsors & Collaborators

Principal Investigators

  • Kenneth Offit, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-03-31
Primary Completion
2021-12-22
Completion
2021-12-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590109 on ClinicalTrials.gov